VolitionRX Ltd. (VNRX)
0.235
0.00 (0.00%)
USD |
NYAM |
Oct 02, 16:00
0.2332
0.00 (0.00%)
After-Hours: 20:00
VolitionRX Debt to Equity Ratio : -0.3547 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3547 |
| March 31, 2026 | -0.366 |
| December 31, 2025 | -0.3348 |
| September 30, 2025 | -0.3251 |
| June 30, 2025 | -0.344 |
| March 31, 2025 | -0.2653 |
| December 31, 2024 | -0.2337 |
| September 30, 2024 | -0.2737 |
| June 30, 2024 | -0.2688 |
| March 31, 2024 | -0.3555 |
| December 31, 2023 | -0.7508 |
| September 30, 2023 | -2.107 |
| June 30, 2023 | 0.8004 |
| March 31, 2023 | -2.041 |
| December 31, 2022 | -1.931 |
| September 30, 2022 | 1.356 |
| June 30, 2022 | 0.9136 |
| March 31, 2022 | 0.4266 |
| December 31, 2021 | 0.2239 |
| September 30, 2021 | 0.1707 |
| June 30, 2021 | 0.1488 |
| March 31, 2021 | 0.1333 |
| December 31, 2020 | 0.2718 |
| September 30, 2020 | 0.1849 |
| June 30, 2020 | 0.1865 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3994 |
| December 31, 2019 | 0.2773 |
| September 30, 2019 | 0.1809 |
| June 30, 2019 | 0.2128 |
| March 31, 2019 | 0.2101 |
| December 31, 2018 | 0.269 |
| September 30, 2018 | 0.2045 |
| June 30, 2018 | 0.3165 |
| March 31, 2018 | 0.1983 |
| December 31, 2017 | 0.2782 |
| September 30, 2017 | 0.1861 |
| June 30, 2017 | 0.1347 |
| March 31, 2017 | 0.0948 |
| December 31, 2016 | 0.0695 |
| September 30, 2016 | 0.0279 |
| June 30, 2016 | 0.0242 |
| March 31, 2016 | 0.0222 |
| December 31, 2015 | 0.0631 |
| September 30, 2015 | 0.0579 |
| June 30, 2015 | 0.0649 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 4.285 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| IDEXX Laboratories, Inc. | 0.6797 |
| Neogen Corp. | 0.388 |
| QuidelOrtho Corp. | 1.733 |
| Aspira Women's Health, Inc. | -0.4279 |
| Lucid Diagnostics, Inc. | 2.280 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.301M |
| Total Liabilities (Quarterly) | 41.38M |
| Shareholders Equity (Quarterly) | -32.16M |
| Current Ratio | 0.3033 |
| Net Debt Paydown Yield | -4.97% |